Results 171 to 180 of about 106,790 (296)
ABSTRACT Introduction Bipolar disorder (BD), characterized by extreme mood shifts between mania and depression, can manifest in childhood, and pose treatment challenges. Treatment for full‐criteria BD I or II in children has been partially described in the literature, but major uncertainties exist regarding non‐classic presentations, which were ...
Demitri F. Papolos+2 more
wiley +1 more source
Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex [PDF]
Wei Zhang+6 more
openalex +1 more source
ABSTRACT Introduction Motor dexterity deficits have been observed both before and during first‐episode psychosis (FEP), suggesting this may be a potential endophenotype for schizophrenia spectrum disorders. We aimed to compare motor dexterity performance in FEP patients, their first‐degree relatives, and controls.
Manuel Sevilla‐Ramos+3 more
wiley +1 more source
Risk of Dementia in Patients Suffering From Psychosis—A Danish Register‐Based Cohort Study
ABSTRACT Objective To investigate the association of psychosis with subsequent risk of dementia and to explore any impact of age at psychosis onset. Methods Using the Danish National health registries, a total of 39,022 patients with a diagnosis of psychosis and a matched sample of 195,109 individuals without psychosis were included in the study.
Simone Normark+3 more
wiley +1 more source
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed. [PDF]
Gangadin SS+13 more
europepmc +1 more source
Can Intensive Psychosocial Treatments Make a Difference in a Time of Atypical Antipsychotics and Managed Care? [PDF]
John Lauriello+2 more
openalex +1 more source
ABSTRACT Objectives Lithium treatment reduces the risk of recurring episodes in bipolar disorder (BD) and probably also in major depressive disorder (MDD) and has evidence of antisuicidal effects. Study objectives were to test for effects of adding lithium treatment for one year to a year of other treatments on risks of illness recurrence, suicidal ...
Maurizio Pompili+7 more
wiley +1 more source
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard+10 more
wiley +1 more source
P02.272 Follow up study of atypical antipsychotics for patients with psychiatric disorders and intellectual disability [PDF]
M. Vanstaelen+3 more
openalex +1 more source